Sign inGet started

Christopher Nishan Garabedian

Insider CIK 1492604 · AVII President and CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SRPT Sarepta Therapeutics, Inc. A Award deriv2015-02-272015-03-037,196— $07,196SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2015-02-272015-03-03365,804— $0365,804SEC↗
SRPT Sarepta Therapeutics, Inc. P Buy2015-02-272015-03-03800$11.82 $9.5K29,552SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2014-02-282014-03-043,444— $03,444SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2014-02-282014-03-04186,556— $0186,556SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2013-06-042013-06-07185,000— $0185,000SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2013-06-042013-06-072,863— $02,863SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2013-06-042013-06-07182,137— $0182,137SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2012-08-232012-08-2770,000— $070,000SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2012-08-232012-08-27150,000— $0150,000SEC↗
AVII AVI BIOPHARMA INC A Award deriv2012-04-242012-04-25245,000— $0245,000SEC↗
AVII AVI BIOPHARMA INC A Award2012-04-242012-04-2581,666— $0511,666SEC↗